Abstract:Objective: Our recent study indicates that administration of adrenomedullin (AM) in combination with AM-binding protein-1 (AMBP-1) before sepsis (i.e., pretreatment) maintains cardiovascular stability and reduces the mortality rate. The aim of the present study was to determine whether administration of AM/AMBP-1 after the onset of sepsis (posttreatment) has any salutary effects on the septic host, and if so, whether AM/AMBP-1 down-regulates proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6. Design: Prospective, controlled, randomized animal study. Setting: A university research laboratory. Subjects: Male adult Sprague-Dawley rats. Interventions: Rats were subjected either to polymicrobial sepsis by cecal ligation and puncture or to sham operation followed by the administration of normal saline solution (i.e., fluid resuscitation). Measurements and main results: At 5 hrs after cecal ligation and puncture, AM (12 microg/kg body weight) and AMBP-1 (40 microg/kg body weight) were administered intravenously over 1 hr. At 20 hrs after cecal ligation and puncture (i.e., the late, hypodynamic stage of sepsis), cardiac output, stroke volume, total peripheral resistance, systemic oxygen delivery, and organ blood flow were determined by radioactive microspheres, and circulating concentrations of proinflammatory cytokines were measured using enzyme-linked immunosorbent assay kits. Moreover, plasma concentrations of transaminases and lactate were measured. The results indicated that administration of AM/AMBP-1 at 5 hrs after cecal ligation and puncture prevented the decrease in measured systemic and regional hemodynamic variables and reduced plasma concentrations of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 at 20 hrs after the onset of sepsis. Moreover, administration of AM/AMBP-1 attenuated hepatic damage and the increase in plasma lactate and prevented hemoconcentration. Conclusion: Administration of AM/AMBP-1 may provide a novel approach to the treatment of sepsis. Moreover, because AM/AMBP-1 significantly reduced circulating concentrations of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6, down-regulation of those proinflammatory cytokines by AM/AMBP-1 appears to play an important role for the beneficial effects of these agents in polymicrobial sepsis.

Synthesis of Novel Biomaterial for the Treatment of Sepsis in Rats

Extraction of Ginsenoside Rg2 from Stems-Leaves of Panax Ginseng and Its Protective Effect on Myocardial Injury in Rats with Sepsis

Effect of Glutamine on Caspase-3 Mrna and Protein Expression in the Myocardium of Rats with Sepsis

[Changes in Expressions of the Myocardial Toll-like Receptor 4, Tumor Necrosis Factor-Alpha and Interleukin-6 Mrna in Rat with Sepsis].

Effects of glutamine on expressions of the myocardial Bcl-2/Bax in rats with sepsis

Glutamine Ameliorates Lipopolysaccharide‑induced Cardiac Dysfunction by Regulating the Toll‑like Receptor 4/mitogen‑activated Protein Kinase/nuclear Factor‑kb Signaling Pathway

Mitochondrial aldehyde dehydrogenase activity protects against lipopolysaccharide‑induced cardiac dysfunction in rats.

Protection of resveratrol on acute kidney injury in septic rats

Protective Effects of Glutamine on Cardiac Muscle Cell in Septic Model Rats

Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: down-regulation of proinflammatory cytokines

Protective effects of glycyrrhizin on sepsis-induced acute lung injury in rats

Sinomenine Hydrochloride Protects Against Polymicrobial Sepsis Via Autophagy

The effects of TNF on the glutamine-enhanced protein synthesis in rats' tissues

Glutamine Attenuates Lipopolysaccharide-Induced Acute Lung Injury.

Glutamine reduces myocardial cell apoptosis in a rat model of sepsis by promoting expression of heat shock protein 90.

Protective effect and mechanism of γ-secretase inhibitor on myocardial injury in sepsis rats

Resveratrol Protects the Myocardium in Sepsis by Activating the Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway and Inhibiting the Nuclear Factor-κB (NF-κB) Signaling Pathway

Protective effects of glutamine on septic mice

Effects of Glutamine on Secretion Suppression of RAW 264.7 Cells Induced by Mesenteric Lymph in Rats with Sepsis

Transcriptomics combined with metabolomics analysis of the mechanism of agmatine in the treatment of septic liver injury

Human Adrenomedullin and Its Binding Protein Ameliorate Sepsis-Induced Organ Injury and Mortality in Jaundiced Rats